Literature DB >> 28874534

Treg-specific IL-27Rα deletion uncovers a key role for IL-27 in Treg function to control autoimmunity.

Jeongsu Do1, Dongkyun Kim1, Sohee Kim1, Alice Valentin-Torres2, Nina Dvorina1, Eunjung Jang1, Vivekananthan Nagarajavel3, Tara M DeSilva2, Xiaoxia Li1, Angela H Ting3, Dario A A Vignali4,5, Stephen A Stohlman2, William M Baldwin1, Booki Min6.   

Abstract

Dysregulated Foxp3+ Treg functions result in uncontrolled immune activation and autoimmunity. Therefore, identifying cellular factors modulating Treg functions is an area of great importance. Here, using Treg-specific Il27ra-/- mice, we report that IL-27 signaling in Foxp3+ Tregs is essential for Tregs to control autoimmune inflammation in the central nervous system (CNS). Following experimental autoimmune encephalomyelitis (EAE) induction, Treg-specific Il27ra-/- mice develop more severe EAE. Consistent with the severe disease, the numbers of IFNγ- and IL-17-producing CD4 T cells infiltrating the CNS tissues are greater in these mice. Treg accumulation in the inflamed CNS tissues is not affected by the lack of IL-27 signaling in Tregs, suggesting a functional defect of Il27ra-/- Tregs. IL-10 production by conventional CD4 T cells and their CNS accumulation are rather elevated in Treg-specific Il27ra-/- mice. Analysis with Treg fate-mapping reporter mice further demonstrates that IL-27 signaling in Tregs may control stability of Foxp3 expression. Finally, systemic administration of recombinant IL-27 in Treg-specific Il27ra-/- mice fails to ameliorate the disease even in the presence of IL-27-responsive conventional CD4 T cells. These findings uncover a previously unknown role of IL-27 in regulating Treg function to control autoimmune inflammation.

Entities:  

Keywords:  Foxp3+ regulatory T cells; IL-27; Tr1 cells; autoimmunity

Mesh:

Substances:

Year:  2017        PMID: 28874534      PMCID: PMC5617261          DOI: 10.1073/pnas.1703100114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Science       Date:  2003-01-16       Impact factor: 47.728

2.  IL-27 is required for shaping the magnitude, affinity distribution, and memory of T cells responding to subunit immunization.

Authors:  Nathan D Pennock; Laurent Gapin; Ross M Kedl
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

3.  A role for IL-27 in limiting T regulatory cell populations.

Authors:  Elia D Tait Wojno; Nancy Hosken; Jason S Stumhofer; Aisling C O'Hara; Elizabeth Mauldin; Qun Fang; Laurence A Turka; Steven D Levin; Christopher A Hunter
Journal:  J Immunol       Date:  2011-05-27       Impact factor: 5.422

4.  A soluble form of IL-27Rα is a natural IL-27 antagonist.

Authors:  Céline Dietrich; Sophie Candon; Frank M Ruemmele; Odile Devergne
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

5.  Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis.

Authors:  Noriko Komatsu; Kazuo Okamoto; Shinichiro Sawa; Tomoki Nakashima; Masatsugu Oh-hora; Tatsuhiko Kodama; Sakae Tanaka; Jeffrey A Bluestone; Hiroshi Takayanagi
Journal:  Nat Med       Date:  2013-12-22       Impact factor: 53.440

6.  IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells.

Authors:  Caroline Diveu; Mandy J McGeachy; Katia Boniface; Jason S Stumhofer; Manjiri Sathe; Barbara Joyce-Shaikh; Yi Chen; Cristina M Tato; Terrill K McClanahan; René de Waal Malefyt; Christopher A Hunter; Daniel J Cua; Robert A Kastelein
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

7.  CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling.

Authors:  S Hannier; M Tournier; G Bismuth; F Triebel
Journal:  J Immunol       Date:  1998-10-15       Impact factor: 5.422

8.  Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells.

Authors:  Takahisa Miyao; Stefan Floess; Ruka Setoguchi; Hervé Luche; Hans Joerg Fehling; Herman Waldmann; Jochen Huehn; Shohei Hori
Journal:  Immunity       Date:  2012-02-09       Impact factor: 31.745

9.  Independent and interdependent immunoregulatory effects of IL-27, IFN-β, and IL-10 in the suppression of human Th17 cells and murine experimental autoimmune encephalomyelitis.

Authors:  Denise C Fitzgerald; Zoë Fonseca-Kelly; Melissa L Cullimore; Pegah Safabakhsh; Christiaan J M Saris; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

10.  In vivo action of IL-27: reciprocal regulation of Th17 and Treg cells in collagen-induced arthritis.

Authors:  Su-Jin Moon; Jin-Sil Park; Yu-Jung Heo; Chang-Min Kang; Eun-Kyung Kim; Mi-Ae Lim; Jun-Geol Ryu; Seong Jeong Park; Kyung Su Park; Young-Chul Sung; Sung-Hwan Park; Ho-Youn Kim; Jun-Ki Min; Mi-La Cho
Journal:  Exp Mol Med       Date:  2013-10-04       Impact factor: 8.718

View more
  35 in total

1.  IL-27 confers a protumorigenic activity of regulatory T cells via CD39.

Authors:  Young-Jun Park; Heeju Ryu; Garam Choi; Byung-Seok Kim; Eun Sook Hwang; Hun Sik Kim; Yeonseok Chung
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-04       Impact factor: 11.205

Review 2.  Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology.

Authors:  Susanne Juhl Pedersen; Walter P Maksymowych
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

Review 3.  The Immunobiology of the Interleukin-12 Family: Room for Discovery.

Authors:  Elia D Tait Wojno; Christopher A Hunter; Jason S Stumhofer
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

4.  Assessment of the Impact of Cytokines on TFH, TREG, and TFR Cell Populations After Influenza Infection.

Authors:  Amber Papillion; Meagan M Jenkins; André Ballesteros-Tato
Journal:  Methods Mol Biol       Date:  2022

5.  Altered peripheral B lymphocyte homeostasis and functions mediated by IL-27 via activating the mammalian target of rapamycin signaling pathway in patients with rheumatoid arthritis.

Authors:  Yawei Tang; Ziran Bai; Jingjing Qi; Zhimin Lu; Guan Wang; Minli Jin; Bing Wang; Haifeng Chen; Xia Li
Journal:  Clin Exp Immunol       Date:  2021-10-05       Impact factor: 4.330

Review 6.  Regulation of myelopoiesis by proinflammatory cytokines in infectious diseases.

Authors:  Yukino Chiba; Izuru Mizoguchi; Hideaki Hasegawa; Mio Ohashi; Naoko Orii; Taro Nagai; Miyaka Sugahara; Yasunori Miyamoto; Mingli Xu; Toshiyuki Owaki; Takayuki Yoshimoto
Journal:  Cell Mol Life Sci       Date:  2017-12-07       Impact factor: 9.261

7.  Cutting Edge: IL-27 Attenuates Autoimmune Neuroinflammation via Regulatory T Cell/Lag3-Dependent but IL-10-Independent Mechanisms In Vivo.

Authors:  Dongkyun Kim; Hongnga T Le; Quang Tam Nguyen; Sohee Kim; Juyeun Lee; Booki Min
Journal:  J Immunol       Date:  2019-01-30       Impact factor: 5.422

8.  IL-27 gene therapy induces depletion of Tregs and enhances the efficacy of cancer immunotherapy.

Authors:  Jianmin Zhu; Jin-Qing Liu; Min Shi; Xinhua Cheng; Miao Ding; Jianchao C Zhang; Jonathan P Davis; Sanjay Varikuti; Abhay R Satoskar; Lanchun Lu; Xueliang Pan; Pan Zheng; Yang Liu; Xue-Feng Bai
Journal:  JCI Insight       Date:  2018-04-05

9.  Eleven loci with new reproducible genetic associations with allergic disease risk.

Authors:  Manuel A R Ferreira; Judith M Vonk; Hansjörg Baurecht; Ingo Marenholz; Chao Tian; Joshua D Hoffman; Quinta Helmer; Annika Tillander; Vilhelmina Ullemar; Yi Lu; Franz Rüschendorf; David A Hinds; Norbert Hübner; Stephan Weidinger; Patrik K E Magnusson; Eric Jorgenson; Young-Ae Lee; Dorret I Boomsma; Robert Karlsson; Catarina Almqvist; Gerard H Koppelman; Lavinia Paternoster
Journal:  J Allergy Clin Immunol       Date:  2018-04-19       Impact factor: 10.793

Review 10.  IL-30 (IL-27A): a familiar stranger in immunity, inflammation, and cancer.

Authors:  Booki Min; Dongkyun Kim; Matthias J Feige
Journal:  Exp Mol Med       Date:  2021-05-28       Impact factor: 12.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.